Drug Trial Radar · NCT06625060
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Last checked: Nov 19, 2026Latest source record: Sep 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
670
Actual
Start
Oct 10, 2024
Primary completion
Oct 31, 2027
Study completion Oct 31, 2027
Sponsor
- Lead sponsor
- IpsenIndustry
- Sponsor type
- Industry
- First posted
- Oct 3, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or being sick and a sensitivity to bright lights and sound. Migraines are caused by a series of events when the brain gets stimulated or activated, which causes the release of chemicals that cause pain. Corabotase (also known as IPN10200) is a medication that stops the release of these chemical messengers. Participants with episodic migraine (EM) or chronic migraine (CM) will be included in both Step 1 and Step 2. "Headache days" are when participants experience headaches that meet the criteria for a migraine or a headache without the additional migraine-specific symptoms. "Migraine days" occur when the headache displays clear migraine characteristics. This study aims to determine: * The safety and efficacy of injecting Corabotase directly into the muscles of the head and neck to prevent EM and CM, * The right amount (dose) of Corabotase to inject at each point, * The total amount (dose) of Corabotase that provides the best balance between safety and efficacy preventing migraines. Participants will need to complete a daily electronic migraine Diary (eDiary) and questionnaires throughout the study. The total study duration for a participant will be up to 44 weeks.
Conditions
- Episodic Migraine
- Chronic Migraine
Interventions
CorabotaseBiological
Lyophilised powder
PlaceboOther
Excipients without active substance, Lyophilised powder
Corabotase dose ABiological
Lyophilised powder
Corabotase dose BBiological
Lyophilised powder
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of participants experiencing any Adverse Event (AEs) including treatment emergent adverse events (TEAEs), serious adverse events (SAEs), adverse event of special interest (AESI) and AE leading to treatment discontinuationTime frame: For step 1: From baseline until end of study at Week 36
- Percentage of Participants with clinically significant changes from baseline in Laboratory ParametersTime frame: For step 1: At all timepoints post injection until Week 36
- Percentage of Participants With Clinically Significant Changes from baseline in Vital SignsTime frame: For step 1: At all timepoints post injection until Week 36
- Percentage of participants with clinically significant change from baseline in facial examinationTime frame: For step 1: At all timepoints post injection until Week 36
- Percentage of participants with clinically significant change from baseline in 12-lead Electrocardiogram (ECG) readingsTime frame: For step 1: At all timepoints post injection until Week 36
- Treatment-emergence of suicidal ideation/suicidal behaviourTime frame: For step 1: At all timepoints post injection until Week 36
- Percentage of participants with Binding antibodies to IPN10200Time frame: For step 1: At baseline, Week 4, Week 12 and Week 36.
- Percentage of participants with neutralising antibodies to IPN10200Time frame: For step 1: At baseline, Week 4, Week 12 and Week 36.
- Change from baseline in the number of Monthly migraine days (MMD)sTime frame: For step 2: At Week 12 (Weeks 9-12).
Locations
162 sites in 14 countries. Site status is shown where the registry gives one.
Central Research Associates
Birmingham, Alabama
Rehabilitation & Neurological Services, LLC
Huntsville, Alabama
MD First Research - Chandler - Neurology
Chandler, Arizona
MD First Research - Chandler
Chandler, Arizona
Axiom Research, LLC
Apple Valley, California
Profound Research. LLC - NCSC
Carlsbad, California
M3Wake -PRI Encino
Encino, California
WR-PRI Encino
Encino, California
Neuro-Pain Medical Center
Fresno, California
Fullerton Neurological Center - Neurology
Fullerton, California
Neurology Center of North Orange County
Fullerton, California
Kaizen Brain Center
La Jolla, California
Pharmacology Research Institute (PRI)
Los Alamitos, California
Pharmacology Research Institute (PRI) - Los Alamitos/Long Beach
Newport Beach, California
Profound Research, LLC
Pasadena, California
Acclaim Clinical Research - Internal Medicine
San Diego, California
Clinical Trials Management LLC
Thousand Oaks, California
Alliance Clinical West Hills (Focus Clinical Research)
West Hills, California
Advanced Neuroscience Research Center, LLC
Fort Collins, Colorado
Advanced Neuroscience Research Center, LLC - Neurology
Fort Collins, Colorado
New England Institute for Neurology and Headache (NEINH)/Medical Practice
Stamford, Connecticut
Neurology Offices
Boca Raton, Florida
AGA Clinical Trials
Hialeah, Florida
M3 Wake Research/MSRA, LLC
Lake City, Florida
M3 Wake Research/MSRA,LLC
Lake City, Florida
Renstar Medical Research
Ocala, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Emerald Coast Center For Neurological Disorders
Pensacola, Florida
Conquest Research
Winter Park, Florida
NeuroTrials Research, Inc.
Atlanta, Georgia
Crescent City Headache and Neurology Center, LLC
Chalmette, Louisiana
Ochsner Health Center - Covington
Covington, Louisiana
DelRicht Research
New Orleans, Louisiana
DelRicht Research at Touro Medical Center
New Orleans, Louisiana
LSU Healthcare Network Orthopedic & Sports Medicine
New Orleans, Louisiana
MedStar Neurosciences and Rehabilitation Research Network
Baltimore, Maryland
MedStar Neurosciences and Rehabilitation
Baltimore, Maryland
MedStar Franklin Square Hospital Center
Baltimore, Maryland
Medstar Franklin Square Medical Center
Baltimore, Maryland
Neurology Center of NE,PC - Neurology
Foxborough, Massachusetts
Showing 40 of 162 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.